MarketScreener Homepage > Equities > Nasdaq > VYNE Therapeutics Inc. VYNE

Report

Delayed Nasdaq - 01/26 04:00:00 pm
2.5	USD		-5.30%

01/26

Wall Street Wavers Pre-Bell Amid Earnings Deluge

01/26

VYNE THERAPEUTICS : Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

01/26

VYNE THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-K)

Calendar

Upcoming events on VYNE THERAPEUTICS INC.

- No events available -

Past events on VYNE THERAPEUTICS INC.

06/02/20 \| 02:00pm		Jefferies Virtual Healthcare Conference
05/11/20 \| 08:30am		Q1 2020 Earnings Call
05/11/20 \| 07:00am		Q1 2020 Earnings Release
04/06/20 \| 08:30am		Serlopitant Phase 3 Results Update call

ERROR : Probleme Sector : You have an error in your SQL syntax; check the manual that corresponds to your MySQL server version for the right syntax to use near '100000000)' at line 1 .

Upcoming sector events for VYNE THERAPEUTICS INC.

- No events available -

More events

Past sector events for VYNE THERAPEUTICS INC.

- No events available -

Annual publications

Annual results		2015	2016	2017	2018	2019	2020 (e)
Sales M $	Released Forecast Spread	0,85 3,08 -72%	5,53 4,85 14%	3,67 3,66 0,28%	3,60 3,76 -4,4%	0,44 2,34 -81%	21,9
Operating income (EBITDA) M $	Released Forecast Spread		-29,5 -25,8 -14%	-65,4 -62,5 -4,6%	-74,6 -74,2 -0,57%
Operating profit (EBIT) M $	Released Forecast Spread	-16,9 -15,9 -6,7%	-29,7 -27,2 -8,9%	-65,6 -63,9 -2,7%	-74,9 -72,5 -3,3%	-95,9 -99,9 4,0%	-190
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-16,5 -15,4 -7,0%	-28,9 -25,4 -14%	-64,6 -62,8 -2,8%	-74,0 -72,3 -2,3%	-95,4 -99,3 4,0%	-258
Net income M $	Released Forecast Spread	-16,5 -15,4 -7,2%	-29,3 -25,0 -17%	-65,7 -63,0 -4,3%	-74,2 -73,0 -1,6%	-95,2 -99,3 4,2%	-258
EPS	Released Forecast Spread						-2,29
Announcement Date		03/02/2016	02/21/2017	02/27/2018	02/28/2019	03/12/2020

Quarterly publications

Previous period

Next period

Quarterly results		2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4 (e)	2021 Q1 (e)	2021 Q2 (e)	2021 Q3 (e)	2021 Q4 (e)
Sales M $	Released Forecast Spread	0,96 1,15 -16%	0,87 1,07 -19%	0,86 1,03 -17%	0,31 1,02 -70%	0,80	0,75	0,14	1,75 1,05 66%	11,7 1,86 529%	3,27 3,25 0,50%	5,18	9,10	14,1	20,2	25,9
Operating income (EBITDA) M $	Released Forecast Spread	-18,7 -20,5 8,9%	-15,5 -17,1 9,5%	-14,7 -14,3 -2,9%	-15,8 -10,8 -46%
Operating profit (EBIT) M $	Released Forecast Spread	-18,8 -21,8 14%	-15,6 -15,8 1,4%	-14,8 -12,5 -18%	-15,9 -16,3 2,3%	-19,4 -20,5 5,3%	-23,2 -25,2 8,0%	-37,4 -25,3 -48%	-39,9 -39,1 -2,0%	-167 -28,3 -490%	-23,5 -26,9 13%	-21,9	-19,2	-15,7	-11,5	-6,50
Pre-Tax Profit (EBT) M $	Released Forecast Spread	-18,5 -22,7 18%	-15,5 -15,7 1,4%	-14,3 -12,4 -15%	-15,4 -16,0 4,1%	-19,0 -20,3 6,3%	-23,2 -25,2 8,2%	-37,8 -25,3 -49%	-40,2 -42,9 6,3%	-168 -30,9 -442%	-24,7 -29,6 16%	-24,3	-18,8	-16,2	-15,1	-9,00
Net income M $	Released Forecast Spread	-18,6 -22,9 19%	-15,5 -15,7 1,7%	-14,1 -13,0 -8,3%	-15,2 -18,8 19%	-19,0 -20,2 5,8%	-23,2 -25,2 8,2%	-37,8 -25,3 -49%	-40,2 -42,9 6,3%	-167 -30,9 -442%	-24,7 -29,6 16%	-24,4	-18,8	-16,2	-15,1	-9,00
EPS $	Released Forecast Spread								-0,95 -0,71 -34%	-1,21 -0,29 -325%	-0,15 -0,18 17%	-0,14	-0,12	-0,09	-0,07	-0,04
Announcement Date		08/08/2018	11/07/2018	02/28/2019	05/07/2019	08/07/2019	11/11/2019	03/12/2020	05/11/2020	08/06/2020	11/05/2020

Net sales (Year) - Rate of surprise

EPS (Year) - Rate of surprise

Net sales (Quarter) - Rate of surprise

EPS (Quarter) - Rate of surprise